Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

753

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

May 31, 2000

Study Completion Date

May 31, 2000

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
DRUG

insulin aspart

Injected subcutaneously (s.c, under the skin) as meal time insulin

DRUG

human soluble insulin

Injected subcutaneously (s.c, under the skin) as meal time insulin

DRUG

insulin NPH

Will be administrated subcutaneously (s.c, under the skin) once or twice daily as basal insulin

Trial Locations (80)

1030

Novo Nordisk Investigational Site, Vienna

1090

Novo Nordisk Investigational Site, Vienna

2000

Novo Nordisk Investigational Site, Frederiksberg

2400

Novo Nordisk Investigational Site, Copenhagen

2820

Novo Nordisk Investigational Site, Gentofte Municipality

4011

Novo Nordisk Investigational Site, Stavanger

4600

Novo Nordisk Investigational Site, Køge

5021

Novo Nordisk Investigational Site, Bergen

5500

Novo Nordisk Investigational Site, Haugesund

6000

Novo Nordisk Investigational Site, Kolding

7006

Novo Nordisk Investigational Site, Trondheim

8032

Novo Nordisk Investigational Site, Zurich

8036

Novo Nordisk Investigational Site, Graz

19049

Novo Nordisk Investigational Site, Schwerin

20251

Novo Nordisk Investigational Site, Hamburg

24103

Novo Nordisk Investigational Site, Kiel

24939

Novo Nordisk Investigational Site, Flensburg

32454

Novo Nordisk Investigational Site, Bad Oeynhausen

35385

Novo Nordisk Investigational Site, Giessen

39120

Novo Nordisk Investigational Site, Magdeburg

39124

Novo Nordisk Investigational Site, Magdeburg

41061

Novo Nordisk Investigational Site, Mönchengladbach

42117

Novo Nordisk Investigational Site, Wuppertal

42781

Novo Nordisk Investigational Site, Haan

44789

Novo Nordisk Investigational Site, Bochum

45131

Novo Nordisk Investigational Site, Essen

45138

Novo Nordisk Investigational Site, Essen

46145

Novo Nordisk Investigational Site, Oberhausen

48210

Novo Nordisk Investigational Site, Kotka

49179

Novo Nordisk Investigational Site, Ostercappeln

53474

Novo Nordisk Investigational Site, Bad Neuenahr-Ahrweiler

55116

Novo Nordisk Investigational Site, Mainz

55131

Novo Nordisk Investigational Site, Mainz

60590

Novo Nordisk Investigational Site, Frankfurt

65191

Novo Nordisk Investigational Site, Wiesbaden

66299

Novo Nordisk Investigational Site, Friedrichsthal

66740

Novo Nordisk Investigational Site, Saarlouis

70184

Novo Nordisk Investigational Site, Stuttgart

70191

Novo Nordisk Investigational Site, Stuttgart

70210

Novo Nordisk Investigational Site, Kuopio

79106

Novo Nordisk Investigational Site, Freiburg im Breisgau

81925

Novo Nordisk Investigational Site, München

97070

Novo Nordisk Investigational Site, Würzburg

00029

Novo Nordisk Investigational Site, Helsinki

01400

Novo Nordisk Investigational Site, Vantaa

0407

Novo Nordisk Investigational Site, Oslo

791 82

Novo Nordisk Investigational Site, Falun

651 85

Novo Nordisk Investigational Site, Karlstad

ML6 0JS

Novo Nordisk Investigational Site, Airdrie

BA1 3NG

Novo Nordisk Investigational Site, Bath

BB3 3LR

Novo Nordisk Investigational Site, Blackburn

BL1 4QS

Novo Nordisk Investigational Site, Bolton

CF38 1AB

Novo Nordisk Investigational Site, Church Village

PO6 3LY

Novo Nordisk Investigational Site, Cosham

CV1 4FH

Novo Nordisk Investigational Site, Coventry

EH16 4SA

Novo Nordisk Investigational Site, Edinburgh

EH4 2XU

Novo Nordisk Investigational Site, Edinburgh

EX2 5AX

Novo Nordisk Investigational Site, Exeter

ME7 5NY

Novo Nordisk Investigational Site, Gillingham

HU3 2JZ

Novo Nordisk Investigational Site, Hull

IV2 3UJ

Novo Nordisk Investigational Site, Inverness

LE1 5WW

Novo Nordisk Investigational Site, Leicester

E1 1BB

Novo Nordisk Investigational Site, London

TS5 5AZ

Novo Nordisk Investigational Site, Middlesbrough

NE7 7DN

Novo Nordisk Investigational Site, Newcastle

NN1 5BD

Novo Nordisk Investigational Site, Northampton

NG7 2UH

Novo Nordisk Investigational Site, Nottingham

CF64 2XX

Novo Nordisk Investigational Site, Penarth

PL8 8DQ

Novo Nordisk Investigational Site, Plymouth

RG51 5BS

Novo Nordisk Investigational Site, Reading

CV22 5PX

Novo Nordisk Investigational Site, Rugby

SP2 8BJ

Novo Nordisk Investigational Site, Salisbury

S5 7AU

Novo Nordisk Investigational Site, Sheffield

SO14 OYG

Novo Nordisk Investigational Site, Southampton

SG1 4AB

Novo Nordisk Investigational Site, Stevenage

FK8 2AU

Novo Nordisk Investigational Site, Stirling

SA6 6NL

Novo Nordisk Investigational Site, Swansea

WD18 0HB

Novo Nordisk Investigational Site, Watford

L35 5DR

Novo Nordisk Investigational Site, Whiston

YO3 7HE

Novo Nordisk Investigational Site, York

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01707134 - Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes | Biotech Hunter | Biotech Hunter